NO162908C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-fenylpyrano(2,3-beta)-pyridiner. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-fenylpyrano(2,3-beta)-pyridiner.

Info

Publication number
NO162908C
NO162908C NO854110A NO854110A NO162908C NO 162908 C NO162908 C NO 162908C NO 854110 A NO854110 A NO 854110A NO 854110 A NO854110 A NO 854110A NO 162908 C NO162908 C NO 162908C
Authority
NO
Norway
Prior art keywords
phenylpyrano
pyridines
beta
preparation
therapeutically active
Prior art date
Application number
NO854110A
Other languages
English (en)
Other versions
NO854110L (no
NO162908B (no
Inventor
Thomas M Bargar
John K Daniel
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO854110L publication Critical patent/NO854110L/no
Publication of NO162908B publication Critical patent/NO162908B/no
Publication of NO162908C publication Critical patent/NO162908C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO854110A 1984-10-19 1985-10-16 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-fenylpyrano(2,3-beta)-pyridiner. NO162908C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/663,020 US4588733A (en) 1984-10-19 1984-10-19 2-phenylpyrano[2,3-b]pyridines and their use in inhibiting viruses

Publications (3)

Publication Number Publication Date
NO854110L NO854110L (no) 1986-04-21
NO162908B NO162908B (no) 1989-11-27
NO162908C true NO162908C (no) 1990-03-07

Family

ID=24660185

Family Applications (1)

Application Number Title Priority Date Filing Date
NO854110A NO162908C (no) 1984-10-19 1985-10-16 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-fenylpyrano(2,3-beta)-pyridiner.

Country Status (22)

Country Link
US (1) US4588733A (no)
EP (1) EP0178633B1 (no)
JP (1) JPH064633B2 (no)
KR (1) KR900004214B1 (no)
CN (1) CN1007249B (no)
AR (1) AR242956A1 (no)
AT (1) ATE71379T1 (no)
AU (1) AU576906B2 (no)
CA (1) CA1294282C (no)
DE (1) DE3585128D1 (no)
DK (1) DK161328C (no)
ES (2) ES8703873A1 (no)
FI (1) FI83520C (no)
GR (1) GR852532B (no)
HU (1) HU193350B (no)
IE (1) IE58145B1 (no)
IL (1) IL76776A (no)
NO (1) NO162908C (no)
NZ (1) NZ213814A (no)
PH (1) PH23586A (no)
PT (1) PT81329B (no)
ZA (1) ZA857872B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034531A (en) * 1988-12-23 1991-07-23 Schering Corporation Fused polycyclic pyranyl compounds as antiviral agents
WO1993017682A1 (en) * 1992-03-04 1993-09-16 Abbott Laboratories Angiotensin ii receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518273A (en) * 1966-08-03 1970-06-30 Warner Lambert Pharmaceutical Benzopyranquinolinol derivatives and process for their production
EP0004579B1 (en) * 1978-03-15 1982-08-18 The Wellcome Foundation Limited Flavans, process for their preparation and pharmaceutical compositions containing them
US4563468A (en) * 1979-09-13 1986-01-07 Burroughs Wellcome Co. Chemotherapeutic agents
US4801593A (en) * 1979-09-13 1989-01-31 Burroughs Wellcome Co. Chemotherapeutic agents
JPS5651470A (en) * 1979-09-13 1981-05-09 Wellcome Found Flavan derivative
US4371537A (en) * 1981-08-13 1983-02-01 The Dow Chemical Company Sulfur-substituted phenoxypyridines having antiviral activity

Also Published As

Publication number Publication date
EP0178633A2 (en) 1986-04-23
HUT38946A (en) 1986-07-28
IL76776A (en) 1989-08-15
IE58145B1 (en) 1993-07-14
ES8801283A1 (es) 1988-01-01
EP0178633B1 (en) 1992-01-08
AU576906B2 (en) 1988-09-08
KR860003261A (ko) 1986-05-21
CN85109303A (zh) 1986-08-20
FI854026A0 (fi) 1985-10-16
DK161328B (da) 1991-06-24
IE852590L (en) 1986-04-19
EP0178633A3 (en) 1988-06-22
DE3585128D1 (de) 1992-02-20
AU4858885A (en) 1986-04-24
HU193350B (en) 1987-09-28
ES557062A0 (es) 1988-01-01
US4588733A (en) 1986-05-13
ES547983A0 (es) 1987-03-01
ES8703873A1 (es) 1987-03-01
FI83520C (fi) 1991-07-25
DK478685A (da) 1986-04-20
JPH064633B2 (ja) 1994-01-19
PT81329B (pt) 1987-10-20
NO854110L (no) 1986-04-21
JPS61112079A (ja) 1986-05-30
GR852532B (no) 1986-02-19
PH23586A (en) 1989-09-11
ZA857872B (en) 1986-05-28
NZ213814A (en) 1988-05-30
FI83520B (fi) 1991-04-15
ATE71379T1 (de) 1992-01-15
DK161328C (da) 1991-12-09
CA1294282C (en) 1992-01-14
KR900004214B1 (ko) 1990-06-18
CN1007249B (zh) 1990-03-21
PT81329A (en) 1985-11-01
NO162908B (no) 1989-11-27
IL76776A0 (en) 1986-02-28
AR242956A1 (es) 1993-06-30
DK478685D0 (da) 1985-10-18
FI854026L (fi) 1986-04-20

Similar Documents

Publication Publication Date Title
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO822128L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidazo-(1,2-a)-pyridiner og -pyraziner
NO161914C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazo(1,2-a)(1,2)kondenserte ringsystemer.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO156694C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.
NO153370C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, stabile s-adenosylmethionisalter.
NO164472C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte 2-(monokondenserte (3,4- og 5,6)-pyridylalkylensulfinyl)-benzimidazoler.
NO160206C (no) Fremgangsmaate ved fremstilling av isosilybinfri silibinin.
NO162906C (no) Analogifremgangsmaate ved fremstilling av delta22- ellerdelta23- 26,26,26,27,27,27- heksafluor-1alfa,25-dihydroksycholecalciferol.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO163896C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive spiro-(1,8)-nafthyridin-dioner.
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2001